Back to Market Feed

Product Information

STELARA 45 MG/0.5 ML SYRINGE is a brand product labeled by Janssen Biotech, Inc., priced at $29874.4480 per ML under NDC 57894006003. Its NADAC has been published 527 times since Jan 22, 2014.

STELARA 45 MG/0.5 ML SYRINGE

ustekinumab
$29874.4480per ML

Strength

45 mg/.5mL

NDC

57894006003

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

USTEKINUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125261

On Market Since

9/25/2009

Pharmacological Classes

Interleukin-12 Antagonist
Interleukin-12 Antagonists
Interleukin-23 Antagonist
Interleukin-23 Antagonists

Price Statistics

The NADAC for STELARA 45 MG/0.5 ML SYRINGE has been published 527 times since Jan 22, 2014, and over the history we have for it it has risen 123.2%. The table below summarizes its recorded NADAC range and movement.

Current price$29874.4480 per ML
All-time high$29874.4480 (Aug 19, 2026)
All-time low$13383.9280 (Jan 22, 2014)
52-week high$29874.4480
52-week low$28420.6171
Median price$21183.8474
Average price$21236.2715
Largest weekly change+13.1% (Jul 19, 2023)
Weeks tracked527
Tracking sinceJan 22, 2014

Price History

1W

0.0%

1M

0.0%

3M

+0.1%

6M

+0.1%

1Y

+5.1%

3Y

+17.1%

5Y

+32.4%

All

+123.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ustekinumab market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TREMFYA 200 MG/2 ML PEN
Brand
57894065102•Janssen Biotech, Inc.
$7318.9883
per ML
TREMFYA 100 MG/ML SYRINGE
Brand
57894064001•Janssen Biotech, Inc.
$14728.9053
per ML
TREMFYA 100 MG/ML ONE-PRESS
Brand
57894064011•Janssen Biotech, Inc.
$14745.8421
per ML
SKYRIZI 150 MG/ML PEN
Brand
00074210001•AbbVie Inc.
$22761.4629
per ML
SKYRIZI 150 MG/ML SYRINGE
Brand
00074105001•AbbVie Inc.
$22887.4386
per ML

Frequently asked questions

What is the NADAC price of STELARA 45 MG/0.5 ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for STELARA 45 MG/0.5 ML SYRINGE, manufactured by Janssen Biotech, Inc., is $29874.4480 per ML (NDC 57894006003), effective Aug 19, 2026.

How has the price of STELARA 45 MG/0.5 ML SYRINGE changed over time?

Over the history we have for it, the NADAC for STELARA 45 MG/0.5 ML SYRINGE has risen 123.2%. It has been tracked across 527 weekly CMS publications since Jan 22, 2014.

What are the highest and lowest recorded NADAC prices for STELARA 45 MG/0.5 ML SYRINGE?

Since Jan 22, 2014, the NADAC for STELARA 45 MG/0.5 ML SYRINGE has ranged from a low of $13383.9280 (Jan 22, 2014) to a high of $29874.4480 (Aug 19, 2026), with a median of $21183.8474 per ML.

Are there cheaper alternatives to STELARA 45 MG/0.5 ML SYRINGE?

No other NADAC-published product currently shares the active ingredient and strength of STELARA 45 MG/0.5 ML SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures STELARA 45 MG/0.5 ML SYRINGE?

STELARA 45 MG/0.5 ML SYRINGE (NDC 57894006003) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.